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e.2013.03Abstract Alloxan is one of the frequently used beta-cytotoxic agents for the induction of Type-1
diabetes mellitus in animal models and is the drug of choice in rabbits. Its beta-cytotoxic action
results in a sudden release of insulin leading to severe hypoglycaemia and even mortality if glucose
therapy is not given. In the present investigation the pathological effects of alloxan induced acute
hypoglycaemia were studied in rabbits. New Zealand White rabbits, 1–1.5 kg body weight, were
administered alloxan @100 mg/kg b.w., as a single intravenous dose. Blood glucose levels were
monitored (0 h, 20 min, 1 h, and then hourly up to 5 h) and clinical signs noted. Rabbits dead
due to hypoglycaemia were necropsied and histopathology performed. Severe histopathological
changes were observed especially in the brain (neuronal degeneration and necrosis), kidneys
(nephrosis, nephritis) and liver (hepatosis, hepatitis) and also, other organs. Histopathological
observation of beta-cytolysis was suggestive that the drug induced hypoglycaemia is insulin medi-
ated. It was concluded that acute hypoglycaemia causes severe pathological changes and the alloxan
induced immediate hypoglycaemia if not managed in time, might exacerbate the pathological effects
of hyperglycaemia in the induced diabetic models.
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Hypoglycaemia has been recognized as a medical exigency
causing impaired brain function. The changes depend on the
severity and duration of hypoglycaemia. Insulin induced hypo-
glycaemia has been one of the most important complications in
the treatment of Type1 diabetes mellitus.1 Hypoglycaemia canlexandria University Faculty of Medicine.
344 M. Saleem Mir et al.trigger a sequence of events that may be extremely detrimental
from the cardiac point of view. The increased mortality associ-
ated with the intensiﬁed insulin treatment arm of the Action to
Control Cardiovascular Risk in Diabetes (ACCORD) trial has
been ascribed to hypoglycaemia.2 Studies have shown that
hypoglycaemia induces proinﬂammatory changes.3–5 Brain
plays a dominant role in the activation of glucose counter reg-
ulatory defense systems. Measurements of glycogen levels in
humans and rodents under different glycemic conditions have
shown that acute hypoglycaemia depletes whole-brain glyco-
gen stores in an attempt to maintain normal function. The
brain glycogen stores begin to decline when brain glucose
drops to near undetectable levels. However after hypoglycae-
mia, whole brain glycogen stores markedly increase above
baseline levels, so-called supercompensation.1 In addition to
obvious short and long term effects of neuroglycopaenia,6,7
the brain is also vulnerable to systemic inﬂammation because
cytokines from the circulation can potentially enter the brain,
activate microglia and the neurotoxic sequence of events.8
Alloxan, a b-cytotoxic toxic glucose analogue,9 is commonly
used for the development of animal model of Type-I Diabetes
Mellitus (IDDM).10 Alloxan is rapidly taken up by the pancre-
atic b-cells through GLUT2 receptors.11 Its beta-cytotoxic ac-
tion results in sudden release of insulin leading to severe
hypoglycaemia and even mortality if glucose therapy is not gi-
ven.Rabbits are increasingly beingusedas experimental diabetic
models and alloxanhas been the chemical of choice for the devel-
opment of rabbit models of diabetes.12–14 The changes observed
in thesemodels are attributed toAlloxan induced diabetes, with-
out any consideration of the effects of early hypoglycaemia.
Present investigation was aimed at studying the pathological ef-
fects of alloxan induced acute hypoglycaemia in rabbits.
2. Materials and methods
New Zealand white rabbits three months of age and weighing
about 1–1.5 kg were utilized in the study. The experimental pro-
tocols involved in this study were approved by the Institutional
Animal Ethics Committee, Faculty of Veterinary Sciences and
Animal Husbandry, SKUAST-K vide No. AU/FVS/Estt/C-
09/7983-88 dated 19-01-2010 and conforms to the guidelines
for the Care and Use of Laboratory Animals. All the animals
were acclimatized for a period of 7 days prior to the commence-
ment of the experiments. Rabbits were maintained under stan-
dard conditions in the cage system and offered feed and water
ad libtum. Commercially procured rabbit feed and greens were
given twice a day (morning and evening).
Alloxan monohydrate (Sigma–Aldrich) was administered
to 18 rabbits, @100 mg/kg body weight in 1 ml sterile water
as a single intravenous injection through the ear vein using
an insulin syringe. Rabbits were fasted for 18 h prior to Allox-
an administration and the dosage was selected on the basis of
the available literature.
After the administration of beta-cytotoxic drugs, rabbits
were monitored for changes in blood glucose levels using a glu-
cometer (Accu-Chek, Roche diagnostics India Pvt. Ltd.,
Mumbai). Rabbits succumbing to hypoglycaemia were necrop-
sied, gross lesions noted, and representative tissue samples
from various organs were preserved in 10% buffered formal
saline for histopathological examination. The tissues were
processed by routine parafﬁn embedding technique and 5lsections stained with Harris Haematoxilin and Eosin. Parallel
sections were stained with Alcian-Blue PAS (AB-PAS) for acid
and neutral mucopolysaccharides. Pancreatic sections were
also stained for the demonstration of pancreatic islet cells
using Gomori’s modiﬁed Aldehyde Fuchsin Stain.15 Out of
the 16 surviving rabbits, 11 developed hyperglycaemia on
day 7 and were utilized as experimental diabetic models for
further study. Five rabbits showed normal blood glucose levels
range and were euthanized after 15 days.
3. Results
At 20 min post-administration of alloxan blood glucose levels
declined from an average of 112.83 ± 3.270 mg/dL to
98.83 ± 2.275 mg/dL followed by an increasing trend up to
2 h (254.66 ± 3.248 mg/dL). Thereafter the blood glucose lev-
els dropped progressively leading to severe hypoglycaemia by
5 h when glucose levels were between 30 and 58 mg/dL. Two
rabbits showed convulsions and succumbed within 30 min
after going into coma.
At necropsy, the rabbits revealed generalized congestion
involving lungs, liver, kidneys, adrenals, pancreas and brain.
Additionally the liver was darker, heart ﬂabby and dilated,
and the pancreas oedematous (Fig. 1).
Histopathologically, pancreas revealed loss of beta cells and
degenerative changes in exocrine glands. Not all the islets were
uniformly affected. Most of the islets had reduced cellularity
with partial to complete loss of beta-cells. The mildly affected
islets revealed beta-cell degranulation with increased cytoplas-
mic eosinophilia and loss of special staining character (Fig. 2).
Some of the islets contained hyalinized cells where as at other
places ghost islets with total loss of cells were also observed.
Exocrine glands revealed degeneration and cytolysis. Blood
vascular congestion was observed throughout the gland.
Haemorrhages were present in the adnexa.
Brain revealed generalized vascular congestion and neuro-
nal degeneration. Congestion of blood vessels in arachnoid
and piamater, including choroid plexus, and cerebral micro-
vasculature was consistently and widely observed (Fig. 3A).
Focal areas of cerebral oedema were noted. Varying degrees
of neuronal degeneration and necrosis, associated with gliosis
and satellitosis, were noted in different cerebral cortical areas.
Small pyramidal neurons in the second cortical layer appeared
shrunken and stained darker with haematoxylin (Fig. 3B).
Occasionally condensation and rounding of medium and large
pyramidal cells in deeper layers were seen. Degeneration and
necrosis of granule cells were evident in different strata of
the cerebral cortex which was associated with demyelination.
Inﬂammatory reaction was observed in the periependymal re-
gion. The cortical region adjacent to the periependymal area
revealed degeneration of granule cells and dilation of the neu-
ropil (Fig. 3C). Degeneration characterized by condensation of
neurons, and dilation of neuropil associated with satellitosis
was also observed in the caudoputamen. The hippocampus re-
vealed neuronal degeneration and necrosis in all the regions. In
the dentate gyrus, degeneration was more prominent in the
granular cells at the crest, near the cistern velum but extended
medially involving all the layers. Degenerative changes were
characterized by neuronal condensation and dilation of the
neuropil (Fig. 3D). Neuronal degeneration and necrosis
associated with glial cell reaction and satellitosis were also,
Figure 1 Gross pathological changes in alloxan hypoglycaemic: (A) Liver appearing darker in colour and congested; (B) Kidneys
revealing congestion of cortical and medullary regions; (C) Pancreas appearing soft, oedematous and congested; (D) Brain revealing
vascular congestion.
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dophilic necrosis and dilation of the neuropil were prominent
in granule cells. The pyramidal cells in stratum pyramidale re-
vealed increased basophilia, condensation and rounding of the
soma. Neuronal degeneration, necrosis and dilation of neuro-
pil were also, observed in granule cells of CA2 and CA3 re-
gions but pyramidal cells in these regions were relatively less
affected. The amygdaloid nuclei showed neuronal degenera-
tion and necrosis with dilation of neuropil and gliosis. Areas
closest to the lateral ventricles were more severely affected
and at places revealed necrosis with accumulation of glial cells.
Cerebellar meninges and vascular plexus were markedly con-
gested. Severe microvascular congestion was observed in the
cerebellar cortex including both the inner granular layer and
the outer molecular layer. Haemorrhage was noted in the gran-
ular layer (Fig. 4A). Neuronal degeneration was evident in the
granular and molecular layers, which was characterized by in-
creased basophilia and condensation of the soma. Purkinje
cells were not uniformly affected. While they were completely
normal in some regions, degeneration and necrosis with the
loss of cellular details as well as neuronolysis was observed
in other areas (Fig. 4B). Staining of the parallel sections with
combined Alcian Blue Periodic Acid Shiff (AB-PAS) technique
revealed the nissl granules in normal pyramidal neurons and
nucleus of the glial cells to be highly positive for acid muco-
polysaccharides, while the cytoplasm of the pyramidal neurons
was slightly positive (Fig. 4C). Degenerating and necrotic neu-
rons including the degeneration of purkinje cells revealed loss
of nissl substance and were only slightly positive for acid
mucopolysaccharides (Fig. 4D). However, acid mucopolysac-
charide reaction was normal in the granular layer.Kidneys revealed vascular congestion and nephrotic changes
both in cortical and medullary regions. Glomeruli were congested
and frequently revealed hypercellularity and reduced peri-glomer-
ular space (Fig. 5A). Some glomeruli revealed hypocellularity,
hypersegmentation or shrinkage with the widening of peri-glomer-
ular space. Convoluted tubules in the cortical region revealed
degenerative changes characterized by swollen epithelium with
indistinct cell boundaries and increased eosinophilia. Frequently
necrosis and loss of tubular epithelium was noted. Focal nephritis
associated with mononuclear cell inﬁltration was also observed
(Fig. 5B). Vascular congestion was more prominent in the medul-
lary region. Medullary tubules also revealed degeneration of the
tubular epithelium characterized by cellular swelling and increased
eosinophilia (Fig. 5C).Vacuolar changeswere frequentlyobserved.
Focal interstitial nephritis was occasionally observed (Fig. 5D, E).
AB-PAS staining revealed a nucleus of epithelial cells and the inﬁl-
trating cells, in the renal cortex and medulla, positive for acid
mucopolysaccharides (Fig. 5F).
Liver revealed vascular congestion, hepatocellular degener-
ation, necrosis and sinusoidal dilatation. Hepatocellular necro-
sis was markedly characterized by nuclear pyknosis,
karyorrhexis, karyolysis and indistinct cell boundaries
(Fig. 6A). Severe vacuolar changes were observed especially
in the sub-capsular region (Fig. 6B).
Lungs revealed wide-spread vascular engorgement and
emphysema associated with atelectasis in adjacent areas
(Fig. 7A). Mild degrees of haemorrhages were observed in
the alveolar spaces. Peribronchial lymphoid hyperplasia was
a frequent observation (Fig. 7B). AB-PAS staining revealed
bronchial lining epithelium and peribronchial lymphoid tissue
positive for acid mucopolysaccharides (Fig. 7C, D).
Figure 2 Section of pancreas from control rabbit revealing (A) Normal islet and exocrine glands. H&E X100 (OZ x6.2), (B) Normal islet
with beta-cells staining blue. MAF, X400 (OZ x3.5); and from alloxan hypoglycaemic rabbit revealing (C) Islet with reduced cellularity
and acinar cell degeneration. H&E X100 (OZ x7.5), (D) Islet with reduced cellularity. H.E. X400 (OZ x4.1), (E, F) Islet with reduced
cellularity due to beta-cell loss. MAF, X100 (OZ x3.5).
346 M. Saleem Mir et al.Heart revealed vascular congestion in epicardium, myocar-
dium and endocardium (Fig. 8A). Myocytes revealed the cyto-
plasmic rarefaction with vacuolar appearance (Fig. 8B).
Vascular congestion and haemorrhages were prominent
features in the spleen. Mild depletion of lymphoid cells was
also observed focally (Fig. 9A).
Mesenteric lymph node (MLN) revealed lymphoid depletion
causing thinning and rarefaction of the lymphoid tissue which
was associated with a histiocytic reaction (Fig. 9B,C). Frequently
congestion and haemorrhage were also observed (Fig. 9D).
Adrenal revealed mild haemorrhages in the cortex and
degenerative changes in all the layers (Fig. 10A). Haemorrhage
was more severe at the cortico–medullary junction (Fig. 10B).
4. Discussion
The alloxan induced severe hypoglycaemia has been attributed
to hyperinsulinaemia following beta-cytolysis caused by alteredredox potential and the generation of ROS16 and disturbance in
intracellular calcium homoeostasis.17–19 The b-cell degranula-
tion and b-cytolysis was in consistence with pathomorphologi-
cal alterations observed in the pancreas. Histopathologically,
islets were variably affected ranging fromdegranulation to com-
plete cytolysis. Species and individual variations in susceptibility
to the beta-cytotoxic effects of Alloxan have been reported.20
Present study conﬁrms variation among islets from individual
rabbit whichmay be attributed to a variation in the anti-oxidant
status, besides the size andmaturity of the cells. Also, the regen-
eration of b-cells, following Alloxan induced beta-cytolysis, has
been recognized to start within 12 h.20,21 The occasional pres-
ence of ghost islets reﬂect the susceptibility of non-b islet cells
to toxic effects of the drugs but need further investigation vis-
a`-vis their physiological status. Direct toxic effects of the drug
on acinar cells have been reported by earlier workers.22
Alloxan induced hypoglycaemia was associated withmarked
and widespread CNS lesions. Besides vascular congestion,
Figure 3 Section of brain from alloxan hypoglycaemic rabbit revealing (A) Meningeal congestion. H&E X100 (OZ x3.0); (B) Shrinking
of granule cells in cerebral cortex H&E X400 (OZ x3.5); (C) Inﬂammatory reaction in periependymal region. H&E X100 (OZ x4.0); (D)
Degeneration of granule cells and dilation of neuropil in the dentate gyrus. H&E X100 (OZ x3.5).
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ation and necrosis were noted in all layers of the cerebral cortex,
caudoputamen, different parts of the hippocampus including
dentate gyrus, cornu ammonis, and subiculum as well as the cer-
ebellum involving purkinje cells. The nature and pattern of his-
topathological changes observed are in concordance with the
reports in the ratmodel.23 Brain is especially sensitive to lowered
blood glucose levels owing to limited glucose transport activity
in the blood brain barrier and high rates of cellular glucose
metabolism.24,25 Dynamic measurement of glycogen levels, in
humans and rodents under different glycaemic conditions, using
in vivo nuclear magnetic resonance (NMR) spectroscopy has re-
vealed the depletion of whole-brain glycogen stores following
acute hypoglycaemia in an attempt to maintain normal func-
tion.26–28 Certain areas like layer 2 of the cerebral cortex, and
subiculum and dentate gyrus in the hippocampus, especially
those closest to the ventricles were more severely and consis-
tently affected. This is in agreement with the earlier reports of re-
gional variation in the susceptibility of brain to hypoglycaemia
induced injury.1,29 An endogenous excitotoxin (neurotoxin) has
been ascribed for the observed effects.30–32 It has been observed
that at glucose levels below 1 mM (18 mg/dL), there is abrupt
brain energy failure causing ﬂat EEG and results in massive re-
lease of the excitatory amino acid aspartate leading to neuronal
calcium ﬂuxes and necrosis. The accumulation of this toxin in
CSF has been incriminated for observed special differences in
the affection of homogenous neuronal populations. Other neu-
rochemical changes include energy depletion, phospholipase
and other enzyme activation, tissue alkalosis and a tendency
for all cellular redox systems to shift towards oxidation.29 Con-
densation and increased basophilia was a characteristic featureof neuronal necrosis. Acidophilic necrosis was occasionally ob-
served. This, also, supports a prominent role of the neurotoxin,
rather than tissue alkalosis, in neuronal necrosis. However, role
of reduced regional blood ﬂow in association with hypoglycae-
mia33 needs to be evaluated.
Further, in present study, changes were also observed in
the white matter. Although, majority of studies report
involvement of only grey matter, case studies in human have
shown extensive white matter injuries either alone or in asso-
ciation with lesions in grey matter.34,35 Studies have shown
that glycogen plays an important role in protecting white
matter against this injury.36 Only astrocytes (not neurons or
oligodendrocytes) contain glycogen which is utilized during
hypoglycaemia and staves off injury. The period of protection
from hypoglycaemic injury is determined by astrocyte glyco-
gen content.37
In the present study, lesions were also noted in the cerebel-
lum involving purkinje cells, and the spinal cord. This is con-
trary to earlier reports wherein the cerebellum has been
invariably reported to be resistant to hypoglycaemia,29 and
may be ascribed to either the more severe nature of hypogly-
caemia in the present study or to a fall in blood ﬂow33 Kim
and coworkers38 also reported an unusual case of episodic
bilateral cerebellar dysfunction caused by hypoglycaemia, with
a quantitative dynamic PET study demonstrating decreased
glucose uptake-to-utilization ratio and increased leak of glu-
cose in the cerebellum. They suggested that the cerebellum is
not invariably resistant to hypoglycaemia.
Renal lesions observed in Alloxan, and Alloxan-STZ hypo-
glycaemia were characterized by vascular congestion, tubular
nephrosis and necrosis involving convoluted tubules and lower
Figure 4 Section of brain from alloxan hypoglycaemic rabbit revealing (A) Severe vascular congestion and haemorrhage of cerebellum
H.E. X100 (OZ x3.0); (B) Degeneration of purkinje cells in the cerebellum. H.E. X400 (OZ x3.3); (C) The Nissl granules in normal
pyramidal neurons and nucleus of the glial cells are highly positive, while the cytoplasm of the pyramidal neurons is slightly positive for
acid mucopolysaccharides. AB-PAS, x400 (OZ x2.8), (D) Glial cells are more positive for acid mucopolysaccharides than degenerating
neurons. AB-PAS, x400 (OZ x4.3).
348 M. Saleem Mir et al.nephron, glomerular congestion and hypercellularity with
reduced Bowman’s space, and interstitial nephritis. Renal
tubular epithelium expresses high levels of Glut2 glucose trans-
porter,39 and hence is sensitive to both Alloxan and STZ tox-
icities although it is partially protected by higher antioxidant
status. Direct nephrotoxic effects of Alloxan have been demon-
strated.40 Further, kidneys play an essential role in glycaemic
control and respond promptly to changes in blood glucose lev-
els.41,42 Hyperinsulinemic–hypoglycaemic state has been ob-
served to shift renal glucose balance towards net release as a
part of counterregulatory mechanism.43,44 The condition if
prolonged may lead to an energy crisis resulting in renal dam-
age. Patrick and coworkers45 reported that acute insulin-in-
duced hypoglycaemia resulted in decreased renal blood ﬂow,
decreased excretion of sodium and dopamine, whereas albu-
min excretion was unaltered. However, contrary to this several
experimental and clinical studies have shown that insulin resis-
tance and hyperinsulinemia induced renal vasodilation causing
glomerular hypertension and hyperﬁltration, which may pre-
dispose individuals to progressive renal dysfunction.46–48 In
conditions of acute hyperinsulinemia, by the administration
of exogenous insulin in normal rats, renal plasma ﬂow and
the glomerular hydrostatic pressure gradient increased signiﬁ-
cantly because of more dilation of afferent arterioles than
efferent ones.46 Hyperinsulinaemia has been reported to pro-
mote the proliferation of renal cells, and stimulate the produc-
tion of insulin-like growth factor-1 and transforming growth
factor-b. It also upregulates the expression of angiotensin-II
type 1 receptor in mesangial cells, thus enhancing the deleteri-ous effects of angiotensin-II in the kidney, and stimulates the
production and renal action of endothelin-1.49
Liver lesions in Alloxan-induced hypoglycaemia included
congestion, hepatosis and necrosis. Alloxan-STZ induced
hypoglycaemia additionally revealed hepatitis and Kupffer cell
hyperplasia. Acute hepatopathy, like nephropathy, may be as-
cribed to direct drug-induced toxicity, hypoglycaemia, or
hyperinsulinaemia. Glut2 has been found to be expressed at
a very high level in the basolateral membranes of hepatocytes39
making them subjects for direct toxicity. Alloxan induced
time- and concentration-dependent damage has been evi-
denced.50 At concentrations of 3.5 mM and above, Alloxan
caused an increase in lactate dehydrogenase (LDH), gluta-
mate-pyruvate transaminase (GPT) and intracellular potas-
sium (K+) leakage, all of which are indices of plasma
membrane damage, and decreased the intracellular reduced
glutathione content (GSH) in suspensions of isolated rat hepa-
tocytes which were partially protected by Preincubation
(10 min) in D-glucose (50 or 100 mM, but not 10 mM).51
Hyperinsulinaemic hypoglycaemia has been reported to alter
liver function in the cow.52
Observation of only mild changes in cardiac muscles may
be attributed to the fact that it uses fatty acid oxidation as
the main source of energy while glucose and lactate account
for only 30% of energy.53 Further, heart can rapidly switch
its substrate selection to accommodate different physiological
and pathphysiological conditions.54,55
The generalized vascular congestion was a consistent
feature. This may be attributed to hypoglycaemia induced
Figure 5 Section of kidney from alloxan hypoglycaemic rabbit revealing (A) Glomerular congestion, mesangial hyperplasia and
degeneration of the lining epithelium of PCTs (H&E X400) (OZ x4.0); (B) Focal interstitial nephritis and glomerular and vascular
congestion. H&E X400 (OZ x4.0); (C) Vascular congestion, and lower nephron nephrosis. H&E X100 (OZ x3.0); (D) Vascular congestion,
haemorrhage, lower nephron nephrosis and focal nephritis. H&E X100 (OZ x3.0); (E) Vascular congestion, lower nephron nephrosis and
focal nephritis. H&E X400 (OZ x3.5); (F) Inﬁltrating cells in the renal cortex staining positive for acid-mucopolysaccharide. AB-PAS,
X400 (OZ x4.0).
Figure 6 Section of the liver from alloxan hypoglycaemic rabbit revealing (A) Severe degeneration of hepatocytes. AB-PAS, X100 (OZ
x5.7); (B) Severe vacuolar changes in the subcapsular region. AB-PAS, X100 (OZ x8.3).
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Figure 7 Section of lungs revealing (A) Vascular engorgement, emphysema and atelectasis. H&E X100 (OZ x3.0); (B) Peribronchial
lymphoid hyperplasia. H&E X100 (OZ x3.0); (C) Peribronchial lymphoid tissue and bronchial epithelium positive for acid
mucopolysaccharides. AB-PAS, X100 (OZ X3.0); (D) Acid mucopolysaccharides positive peribronchial lymphoid tissue. AB-PAS,
X400 (OZ x4.0).
Figure 8 Alloxan hypoglycaemic rabbit, section of heart revealing (A) Vascular congestion. H&E X100 (OZ x6.0); (B) Micro-vascular
congestion and cytoplasmic rarefaction with vacuolar appearance. H.E. X400 (OZ x5.5).
350 M. Saleem Mir et al.increase in blood ﬂow and decreased vascular resistance.56
Inﬂammatory response was a consistent feature in different or-
gans viz. interstitial nephritis, Kupffer cell hyperplasia and
hepatitis, peribronchial lymphoid hyperplasia, and histiocytic
reaction in MLNs. This may be attributed primarily to acute
inﬂammatory response to hyperinsulinaemia which might be
further augmented by tissue damage. Short-term exposure to
hyperinsulinaemia has been shown to upregulate a number
of genes involved in inﬂammation viz. thrombomodulin,
inﬂammatory chemokines (CCL8, CXCL2, and CCL2) and
cytokines (interleukin-1 receptor type I and interferon-c-induc-
ible protein-16).57–59 These results are consistent with thehistopathological observation that the inﬂammatory cells were
principally mononuclear cells. The mild depletion of lymphoid
cells in the spleen and MLN may be attributed to their mobi-
lization under the inﬂuence of an acute release of chemotactic
factors. Further, the generalized vascular disturbance includ-
ing congestion and haemorrhages were observed in all the or-
gans. Upregulation and release of vasoactive substances has
been suggested as a putative mechanism for hypoglycaemic
vascular injury.4 Hypoglycaemia has been incriminated as
one of the important factors for pulmonary hypertension in
human neonates.60 A similar mechanism may be responsible
for the observed lung congestion, oedema and emphysema.
Figure 9 Section of spleen revealing (A) Mild depletion of lymphocytes and haemorrhage. H&E X100 (OZ x3.5); Section of mesenteric
lymph node showing (B) Lymphoid depletion with histiocyte reaction. H&E X100 (OZ x3.0); (C) Higher magniﬁcation of d. H&E X400
(OZ x6.2); (D) Lymphoid depletion, congestion and haemorrhage. H&E X100 (OZ x3.5).
Figure 10 Alloxan hypoglycaemic rabbit Section of the adrenal gland revealing (A) Mild haemorrhage in the cortex, and degenerative
changes in zona glomerulus and zona faciculata. H&E X100 (OZ x3.0); (B) Congestion and haemorrhage in the cortex and medulla. H.E.
X100 (OZ x2.8).
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It is concluded that Alloxan induced acute-hypoglycaemia
caused severe pathological alterations especially in vital organs
viz. brain, kidneys and liver. The changes may be attributed
partly to direct toxic effects of the chemicals, and partly to drug
induced hyperinsulinaemia and hypoglycaemia. If not managed
in time, hypoglycaemia might exacerbate the hyperglycaemia-
induced pathological effects in the induced diabetic models.References
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